Pharmaceutical firms’ revenues up, profitability down

Pharmaceutical companies saw their revenues edge up in the second quarter of the year. But their ability to generate cash from a variety of operating activities fell on worsening profitability as a result of dramatic changes in the business environment such as regulations by the government, conflicts among drug manufacturers, doctors and pharmacists and intense competition among generic drugs.
...